🔴 HCW Biologics is trading 5% down in pre-market

HCW Biologics is trading at $1.48, down 5.34% in pre-market, with no clear company-specific announcement dated October 8 explaining the decline.

• Recent filings disclosed resale registration of up to 1.81 million shares by existing holders; this is background context, not a confirmed catalyst.
• U.S. futures were lower, but supplied index declines were modest and do not establish a cause. No pre-market volume or activity data was provided, so trading activity cannot be assessed.